The Comparison of Educational Effectiveness Between FAST and STROKE 112 in Yunlin Community

January 6, 2021 updated by: National Taiwan University Hospital
FAST and Stroke-112 are two campaigns to reduce the emergency room arrival time of stroke patients. No study has evaluated the effectiveness of these campaigns. This study aimed to compare recalling capacity of people in these two campaigns.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Cerebral vascular accidents have been one of the leading causes of death in Taiwan in recent years. In the modern medical system, treatment for hyperacute stroke including intravenous thrombolysis and intra-arterial thrombectomy. The faster patient received treatment, the better outcome he has.

Prehospital delay of acute stroke treatment has been an important issue in modern medical system. Awareness of stroke symptoms and calling for medical help immediately is the most important part of stroke health education. The most used educational campaign is FAST.

In recent years, there is another stroke educational campaign called STROKE 112. Previous study had showed it has greater acceptance, since the number is easier to remember then letter, especially in non-English speaking countries.

The investigators had conducted a hospital-based randomized study in 2019, which revealed that STROKE 112 had similar, but not superior effectiveness with FAST. However, more study is needed for community-based population.

This study will compare and explore the effectiveness of two stroke educational campaigns, FAST and STROKE 112, on community-based population by using the questionnaire, in Yunlin, Taiwan. The result will been compared and analyzed with previous study, help us modify and enhance our current stroke educational program, shorten the prehospital delay, and improve outcomes of patients with acute stroke.

The subjects will be randomized into either group: FAST or STROKE 112. Then the investigator will give a 15min eduacation. The evaluation will be arranged 5 days and 30 days after the first education, and the outcome is the recalling capacity of the stroke symptoms in the educational campaign.

Study Type

Interventional

Enrollment (Anticipated)

300

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Taiwan
      • Douliu, Taiwan
        • Recruiting
        • National Taiwan University Hospital Yunlin Branch
        • Contact:
          • Dr. Tsai
          • Phone Number: 55687 +886055323911

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • age ≥ 20
  • individuals who could speak either Mandarin or Taiwanese as their mother tongue

Exclusion Criteria:

  • individuals who could not understanding the education campaign(ex. dementia, aphasia)
  • individuals who were previously aware about either campaign

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: FAST
stroke education: FAST
Other: stroke educational campaign: FAST
After randomization, study staff provided 15-minute education on the selected campaign to each individual participant using educational pictures.
Experimental: STROKE 112
stroke education: STROKE 112
Other: stroke educational campaign: STROKE 112
After randomization, study staff provided 15-minute education on the selected campaign to each individual participant using educational pictures.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The recalling capacity of the stroke symptoms mentioned in each campaign
Time Frame: 5 days
Compare recalling capacity of people in these two campaigns: uneven face, weak arm, slurred speech. If the patient could recall one symptom, then he get 1 score. Total score is 3(which means the subject can recall all three symptoms)
5 days
The recalling capacity of the stroke symptoms mentioned in each campaign
Time Frame: 30 days
Compare recalling capacity of people in these two campaigns: uneven face, weak arm, slurred speech. If the patient could recall one symptom, then he get 1 score. Total score is 3(which means the subject can recall all three symptoms)
30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

National Taiwan University Hospital

Investigators

  • Principal Investigator: YiTe Tsai, Bachelor, National Taiwan University Hospital Yunlin Branch

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

January 1, 2021

Primary Completion (Anticipated)

October 31, 2021

Study Completion (Anticipated)

December 31, 2021

Study Registration Dates

First Submitted

January 4, 2021

First Submitted That Met QC Criteria

January 6, 2021

First Posted (Actual)

January 7, 2021

Study Record Updates

Last Update Posted (Actual)

January 7, 2021

Last Update Submitted That Met QC Criteria

January 6, 2021

Last Verified

January 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 202009041RIND

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

No plan to share IPD

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke, Cardiovascular

Clinical Trials on stroke educational campaign: FAST

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Portugal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe